KLSC is honored to be invited to judge the Innov8 Talks at Arab Health Exhibition and Congress which provides a platform for healthcare start-ups and SMEs to present their innovative products to a panel of global thought-leaders and investors.
This annual competition is back for a third year, and if you are a healthcare start-up or you know of any exciting companies out there are invited to submit an application today for a chance to compete and win the best pitch of Arab Health 2021.
The concept:
- 8 minutes to pitch the product to the panel of judges and the wider audience
- You have the chance to win “Best Pitch of the Day” and join the final “Pitch Off”
- Deadline to submit your pitch - Tuesday, 30 April
Submit your application now
The Innovation Committee Judges includes:
- Reenita Das, Senior VP and Partner, Frost and Sullivan, USA
- Dr Mussaad Al-Razouki, Chief Business Development Officer, Kuwait Life Sciences, Kuwait
- Ahmed Banna, Middle East Public Health, Healthcare Consulting and Management Expert, UAE
- Dr Mazin Gadir, Director of Strategic Partnerships, Bid Management and Client Relationship, UAE
- Supreet Manchanda, Founding Partner, Raiven Capital, USA
- Manish Kohli, Senior Advisor, Albright Stonebridge Group, Fellow, HIMSS, USA
- Summer Nasief, Healthcare Digital GM, GE Healthcare, UAE
- Massimo Cannizo, CEO & Co-Founder, GELLIFY Middle East, UAE
- Danielle MacLean, Offering Leader in Watson Health Provider Analytics, IBM Watson, USA
Join us at Innov8 Talks 2021 this year and submit your application today. Innov8 will be fully virtual, with the pitches taking place between 24 May -7 June on the Arab Health virtual platform, with the chance to be seen by our worldwide network of healthcare professionals.
For more information, please feel free to get in touch with: Ayla.C.Iqbal@informa.com
About KLSC:
Kuwait Life Sciences (KLSC) was established in 2010, with a paid-up capital of 18 million Kuwait Dinars (KD) which is equivalent to approximately $60 million US Dollars. KLSC is fully owned by National Technology Enterprises Company. National Technology Enterprises Company (NTEC) was incorporated in November of 2002, by the Kuwait Council of Ministers as a fully owned company by the Kuwait Investment Authority (KIA), the sovereign wealth fund of the State of Kuwait. Capitalized at 100 million Kuwait Dinars (KD) which is equivalent to approximately $350 million US Dollars, NTEC aims to play a vital role in servicing major stakeholders in Kuwait and the Middle East region with their technology requirements.
KLSC focuses on healthcare innovative concepts and demanded services that have a clear and unmet need in the Middle East and North Africa (MENA) region. KLSC has been designed as an integrated healthcare company building unique projects and is considered one of the pioneer venture capitalist and private equity companies in the Middle East that invests globally and operates regionally seeking to advance healthcare services and systems within the region. KLSC supports both public and private sector stakeholders to access emerging technologies, establish unique projects and adopt best practices prevailing in today’s healthcare field. KLSC operates in healthcare investment, life sciences training, medical technology, and pharmaceutical distribution.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
